✦ LIBER ✦

Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients

✍ Scribed by Jean-Marc Tourani; Jean-François Timsit; Corine Delaisement; Jean-Claude Balzon; Isabelle Caubarrere; Jacqueline Darse; Antoine Geraads; François-Xavier Lebas; Jean-Marie Andrieu

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 551 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900401)65:7<1472::aid-cncr2820650704>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of concurrent chemotherapy on loc

Effect of concurrent chemotherapy on local control in stage III non small cell lung carcinoma (NSCLC) treated with standard fractionation radiotherapy (RT) : Results of a prospective analysis in 123 patients (PTS)

✍ F. Reboul; Y. Brower; P. Vincent; B. Chauvet; C.Félix Faure; M. Taulelle 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A randomized trial of hybrid administrat

A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma : Results of long term follow-up

✍ Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Haruhito Kamei; Kenichi Gemba; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. In an attempt to determine the efficacy of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) hybrid chemotherapy (HYB), a rapidly alternating chemotherapy, in patients with small cell lung carcinoma (SCLC), the authors conducted a randomized study to